Christian Schade joins Omthera as EVP and CFO
This article was originally published in Scrip
Omthera Pharmaceuticals, a privately-held emerging speciality pharmaceuticals company, has appointed Christian Schade executive vice-president and chief financial officer beginning in early September. Mr Schade most recently served as executive vice-president and chief financial officer at NRG Energy, and before that he was senior vice-president of administration and chief financial officer at Medarex.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.